Medtronic, Inc. (MDT) PT Raised to $94 at BMO Capital on 4Q Beat; 'Strength Across Franchises'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4Q
May 26, 2017 9:52 AM EDTOppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $93.00 (from $87.00) while maintaining a Outperform rating. MDT beat 4Q EPS by $0.02, led by higher constant-currency sales and gross margin along with lower FX headwind to EPS, somewhat offset by higher interest... More
Medtronic (MDT): Raising PT - UBS
May 26, 2017 8:41 AM EDTUBS analyst, Matt Miksic, reiterated his Buy rating on shares of Medtronic, Inc. (NYSE: MDT) and raised the price target to $95 after management delivered very solid F4Q results, reassuring investors of the relatively healthy and stable state of MDT's end-markets and the company's solid... More
Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight
May 26, 2017 7:59 AM EDTBarclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining a Overweight... More
Medtronic, Inc. (MDT) PT Raised to $86 at Morgan Stanley
May 26, 2017 7:39 AM EDTMorgan Stanley raised its price target on Medtronic, Inc. (NYSE: MDT) to $86.00 (from $84.00) while maintaining a Equalweight rating.
... MoreMedtronic, Inc. (MDT) PT Raised to $95 at Cowen on 4Q Report; 'Organic Revenue Growth Trajectory Is Back on Track'
May 25, 2017 5:11 PM EDTCowen raised its price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $86.00) while maintaining a Outperform rating, following the company's fourth quarter earnings report.
Analyst Joshua Jennings notes the company delivered fourth quarter earnings per share and revenue results above consensus projections, as management... More
Medtronic, Inc. (MDT) PT Raised to $91 at Stifel Following 4Q Report; 'Diversified Sales Growth & Robust Margins'
May 25, 2017 3:14 PM EDTStifel raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $84.00) while maintaining a Hold rating, following the company's fourth quarter earnings report.
Analyst Rick Wise notes the company delivered fourth quarter earnings per share and revenues above consensus projections driven... More
Medtronic, Inc. (MDT) PT Raised to $91 at Evercore ISI on Strong 4Q EPS/Revenue Results; 'Gross Margin Beat Despite Mix Shift'
May 25, 2017 11:28 AM EDTEvercore ISI raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $88.50) while maintaining a Outperform rating, following the company's fourth quarter earnings report.
Analyst Vijay Kumar notes the company delivered fourth quarter earnings per share and revenues above consensus projections, as... More
Medtronic (MDT) Tops Q4 EPS by 2c; Sees FY18 Constant Currency Revenue Growth of 4-5%
May 25, 2017 6:46 AM EDT(Updated - May 25, 2017 6:56 AM EDT)
Medtronic (NYSE: MDT) reported Q4 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $7.92 billion versus the consensus estimate of $7.86 billion.
Q4 Revenue of $7.9 Billion Grew 5% as Reported; 5% at Constant CurrencyQ4 GAAP Diluted EPS of $0.84; Q4 Non-GAAP Diluted EPS of $1.33FY17 Revenue of $29.7 Billion Grew 3% as Reported; Approximately 5% on a Constant Currency, Constant Week BasisFY17 GAAP Diluted EPS of $2.89; FY17 Non-GAAP Diluted EPS of $4.60FY17 Cash Flow from Operations of $6.9 Billion; FY17... MoreMedtronic (MDT) Enrolls First Patient in Study of IN.PACT AV Access Drug-Coated Balloon in Patients with ESRD
May 24, 2017 12:15 PM EDTMedtronic plc (NYSE: MDT) today announced that the first patient has been enrolled in the IN.PACT(TM) AV Access Drug-Coated Balloon (DCB) study for use in patients with end-stage renal disease (ESRD). The U.S. Food and Drug Administration (FDA) approved the investigational device exemption (IDE) study to evaluate the safety and efficacy of IN.PACT(TM) AV Access DCB as a treatment for failing arteriovenous (AV) fistulas in ESRD patients.
"We are delighted to enroll and treat the first patient in this significant study of... More
Medtronic (MDT) May IV bid up into Q1 EPS and outlook
May 24, 2017 10:31 AM EDTMedtronic (NYSE: MDT) May call option implied volatility is at 43, June is at 19, July is at 15; compared to its 52-week range of 13 to 19 into the expected release of Q1 results on May 25.
... MoreMazor Robotics (MZOR): Takeout Unlikely Here - Needham
May 24, 2017 6:18 AM EDTNeedham & Company analyst, Mike Matson, reiterated his Hold rating on shares of Mazor Robotics (NASDAQ: MZOR) noting that shares are up significantly year-to-date, in part by speculation that Medtronic (NYSE: MDT) will acquire... More
